The 5-Hydroxytryptamine₄ Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations

10.1007/BF02249415

10.1016/0306-4522(91)90070-5

10.1046/j.1460-9568.2002.02005.x

10.1126/science.7046051

10.1101/lm.68004

Blondel, 1998, Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus, J Neurochem, 70, 2252, 10.1046/j.1471-4159.1998.70062252.x

Boddeke, 1990, Zacopride and BRL 24924 induce an increase in EEG-energy in rats, Br J Pharmacol, 101, 281, 10.1111/j.1476-5381.1990.tb12701.x

10.1002/(SICI)1098-2396(200004)36:1<35::AID-SYN4>3.0.CO;2-Y

10.1007/s00210-004-0919-4

10.1016/S0014-2999(01)01087-1

10.1016/j.bbr.2007.10.008

10.1046/j.1460-9568.2001.01361.x

Claeysen, 1999, Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain, Mol Pharmacol, 55, 910

10.1097/00001756-199406020-00018

10.1016/S0197-0186(98)00074-6

Dumuis, 1988, A nonclassical 5-hyrdoxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system, Mol Pharmacol, 34, 880

10.1016/S0165-6147(00)89081-1

10.1016/0028-3908(96)00191-8

10.1016/S0028-3908(97)00055-5

Galeotti, 1998, Role of 5-HT4 receptors in the mouse passive avoidance test, J Pharmcol Exp Ther, 286, 1115

Gerald, 1995, The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants, EMBO J, 14, 2806, 10.1002/j.1460-2075.1995.tb07280.x

10.1016/j.pharmthera.2009.03.002

10.1124/jpet.107.130070

10.1016/j.ejphar.2006.11.048

Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, National Academies Press, Washington, DC, National Institutes of Health Publication 85-23.

10.1523/JNEUROSCI.3737-05c.2006

10.1002/bdd.325

Kinney, 1999, Cognition-enhancing drugs increase stimulated hippocampal θ rhythm amplitude in the urethane-anesthetized rat, J Pharmacol Exp Ther, 291, 99

10.1007/s00210-005-1068-0

10.1016/S0028-3908(96)00169-4

10.2967/jnumed.108.058552

Matsumoto, 2001, Evidence for involvement of central 5-HT4 receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies, J Pharmacol Exp Ther, 296, 676

10.1097/FBP.0b013e3282ee82e3

Medhurst, 2001, Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR, Mol Brain Res, 90, 125, 10.1016/S0169-328X(01)00095-X

10.1254/jphs.FP0072230

10.1016/j.neuropharm.2007.06.016

10.1016/S0166-4328(01)00226-1

10.1002/1099-081X(199912)20:9<429::AID-BDD209>3.0.CO;2-D

10.1111/j.1476-5381.1995.tb13303.x

Roth, 2004, Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders, Psychopharmacology, 174, 17, 10.1007/s00213-003-1683-8

10.1038/mp.2008.28

10.1016/S0304-3940(97)13379-1

10.1016/j.neuropharm.2011.02.026

10.1111/j.1460-9568.2005.04560.x

10.1007/s002130050529

10.1038/sj.mp.4001763

10.1016/S0306-4522(97)00239-X

10.1007/PL00005110